Mako Mining Corp. (MAKOF)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	348	175	136	66	188	206
Market Cap Growth	108.11%	29.25%	106.70%	-65.05%	-8.92%	30.74%
Enterprise Value	343	177	152	81	211	212
Last Close Price	4.34	2.21	2.05	1.04	3.08	3.05
PE Ratio	14.98	9.15	19.93	-	18.83	-
PS Ratio	3.32	1.90	2.06	1.03	5.28	147.31
PB Ratio	4.01	2.28	6.57	4.80	7.22	12.18
P/TBV Ratio	4.01	2.28	6.57	4.80	7.22	12.18
P/FCF Ratio	16.47	8.12	17.58	8.65	-	-
P/OCF Ratio	9.82	5.08	10.87	4.00	72.89	-
EV/Sales Ratio	3.13	1.93	2.31	1.28	5.95	151.33
EV/EBITDA Ratio	6.77	4.24	6.20	6.39	27.35	-
EV/EBIT Ratio	8.00	5.21	13.78	-	453.22	-
EV/FCF Ratio	16.22	8.22	19.77	10.72	-	-
Debt / Equity Ratio	0.07	0.09	0.53	1.15	0.84	1.00
Debt / EBITDA Ratio	0.12	0.16	0.44	1.24	2.82	-
Debt / FCF Ratio	0.27	0.31	1.42	2.08	-	-
Asset Turnover	1.17	1.24	1.52	1.27	0.68	0.04
Inventory Turnover	2.32	3.07	2.50	3.94	4.37	1.40
Quick Ratio	1.03	0.94	0.24	0.11	0.20	0.17
Current Ratio	2.59	1.65	1.73	0.80	0.99	0.20
Return on Equity (ROE)	40.16%	39.27%	39.65%	-60.43%	46.47%	-105.63%
Return on Assets (ROA)	28.55%	28.58%	15.89%	-9.73%	0.56%	-21.11%
Return on Capital (ROIC)	39.51%	36.93%	22.66%	-12.63%	0.71%	-35.65%
Return on Capital Employed (ROCE)	35.70%	37.60%	34.40%	-	1.00%	-
Earnings Yield	6.68%	10.94%	5.02%	-18.27%	5.31%	-5.89%
FCF Yield	6.07%	12.32%	5.69%	11.56%	-1.98%	-18.98%
Buyback Yield / Dilution	-15.48%	-10.82%	-1.08%	0.01%	-6.67%	-23.68%

Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.